DK3594199T3 - Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf - Google Patents
Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf Download PDFInfo
- Publication number
- DK3594199T3 DK3594199T3 DK18182368.3T DK18182368T DK3594199T3 DK 3594199 T3 DK3594199 T3 DK 3594199T3 DK 18182368 T DK18182368 T DK 18182368T DK 3594199 T3 DK3594199 T3 DK 3594199T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystallinic
- nitrotoluene
- flour
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18182368.3A EP3594199B1 (en) | 2018-07-09 | 2018-07-09 | Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3594199T3 true DK3594199T3 (da) | 2020-09-14 |
Family
ID=62904314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18182368.3T DK3594199T3 (da) | 2018-07-09 | 2018-07-09 | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12162815B2 (da) |
| EP (1) | EP3594199B1 (da) |
| JP (1) | JP7407166B2 (da) |
| CN (1) | CN112654602B (da) |
| AU (1) | AU2019303323B2 (da) |
| CA (1) | CA3105559A1 (da) |
| CY (1) | CY1123514T1 (da) |
| DK (1) | DK3594199T3 (da) |
| ES (1) | ES2815899T3 (da) |
| HR (1) | HRP20201198T1 (da) |
| HU (1) | HUE052049T2 (da) |
| LT (1) | LT3594199T (da) |
| MX (1) | MX2021000348A (da) |
| PL (1) | PL3594199T3 (da) |
| PT (1) | PT3594199T (da) |
| SI (1) | SI3594199T1 (da) |
| WO (1) | WO2020011626A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216049B1 (pl) | 2004-06-17 | 2014-02-28 | Cytokinetics Inc | Pochodne mocznika, kompozycje zawierajace pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia niewydolnosci serca |
| EA031185B1 (ru) | 2013-03-14 | 2018-11-30 | Эмджен Инк. | Гетероциклические соединения и способы их применения |
| SI3645518T1 (sl) | 2017-06-30 | 2021-11-30 | Amgen Inc. | Sinteza omekamtiv mekarbila |
| PL3645002T3 (pl) | 2017-06-30 | 2025-03-24 | Amgen Inc. | Sposoby leczenia niewydolności serca za pomocą aktywatorów sarkomerów serca |
| AR112804A1 (es) | 2017-09-13 | 2019-12-11 | Amgen Inc | Compuestos de bisamida que activan el sarcómero y sus usos |
| US11465969B2 (en) | 2018-08-17 | 2022-10-11 | Cytokinetics, Inc. | Salts and crystal forms of omecamtiv mecarbil |
| WO2020131574A1 (en) | 2018-12-18 | 2020-06-25 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| KR20230107282A (ko) | 2020-11-12 | 2023-07-14 | 암젠 인크 | 오메캄티브 메카빌을 투여하여 심부전을 치료하는 방법 |
| BR112023018095A2 (pt) | 2021-03-10 | 2023-12-12 | Amgen Inc | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo |
| WO2024081611A1 (en) | 2022-10-11 | 2024-04-18 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL216049B1 (pl) | 2004-06-17 | 2014-02-28 | Cytokinetics Inc | Pochodne mocznika, kompozycje zawierajace pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia niewydolnosci serca |
| US20070161617A1 (en) | 2005-12-15 | 2007-07-12 | Morgan Bradley P | Certain chemical entities, compositions and methods |
| AR059339A1 (es) | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| CN101177400A (zh) | 2006-11-06 | 2008-05-14 | 吕铁环 | 一种生产2-氟-3-硝基甲苯的方法 |
| WO2009014100A1 (ja) | 2007-07-20 | 2009-01-29 | Chugai Seiyaku Kabushiki Kaisha | ｐ２７蛋白質誘導剤 |
| TWI648273B (zh) * | 2013-02-15 | 2019-01-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺類（三） |
| EP2968180B1 (en) | 2013-03-14 | 2019-04-24 | Amgen Inc. | Heterocyclic compounds and their uses |
| EA031185B1 (ru) | 2013-03-14 | 2018-11-30 | Эмджен Инк. | Гетероциклические соединения и способы их применения |
| EP3250557B1 (en) | 2015-01-29 | 2024-11-20 | Signal Pharmaceuticals, LLC | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| MX379899B (es) | 2015-06-26 | 2025-03-11 | Cytokinetics Inc | Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal |
| EP3266773B1 (en) * | 2016-07-04 | 2018-04-11 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of lapatinib ditosylate monohydrate by means of an improved crystallization procedure |
| SI3645518T1 (sl) | 2017-06-30 | 2021-11-30 | Amgen Inc. | Sinteza omekamtiv mekarbila |
| PL3645002T3 (pl) | 2017-06-30 | 2025-03-24 | Amgen Inc. | Sposoby leczenia niewydolności serca za pomocą aktywatorów sarkomerów serca |
| US11465969B2 (en) | 2018-08-17 | 2022-10-11 | Cytokinetics, Inc. | Salts and crystal forms of omecamtiv mecarbil |
| WO2020131574A1 (en) | 2018-12-18 | 2020-06-25 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| US20230090391A1 (en) | 2020-02-10 | 2023-03-23 | Amgen Inc. | Omecamtiv mecarbil tablet |
| KR20230107282A (ko) | 2020-11-12 | 2023-07-14 | 암젠 인크 | 오메캄티브 메카빌을 투여하여 심부전을 치료하는 방법 |
| BR112023018095A2 (pt) | 2021-03-10 | 2023-12-12 | Amgen Inc | Processos para sintetizar 2-fluoro-3-nitrotolueno, 1-(bromometil)-2-fluoro-3-nitrobenzeno e para preparar omecamtiv mecarbil ou um sal do mesmo, um hidrato do mesmo ou um hidrato de sal do mesmo |
-
2018
- 2018-07-09 PL PL18182368T patent/PL3594199T3/pl unknown
- 2018-07-09 SI SI201830120T patent/SI3594199T1/sl unknown
- 2018-07-09 LT LTEP18182368.3T patent/LT3594199T/lt unknown
- 2018-07-09 HU HUE18182368A patent/HUE052049T2/hu unknown
- 2018-07-09 EP EP18182368.3A patent/EP3594199B1/en active Active
- 2018-07-09 PT PT181823683T patent/PT3594199T/pt unknown
- 2018-07-09 DK DK18182368.3T patent/DK3594199T3/da active
- 2018-07-09 ES ES18182368T patent/ES2815899T3/es active Active
-
2019
- 2019-07-03 AU AU2019303323A patent/AU2019303323B2/en active Active
- 2019-07-03 JP JP2021500471A patent/JP7407166B2/ja active Active
- 2019-07-03 CN CN201980058205.6A patent/CN112654602B/zh active Active
- 2019-07-03 MX MX2021000348A patent/MX2021000348A/es unknown
- 2019-07-03 CA CA3105559A patent/CA3105559A1/en active Pending
- 2019-07-03 WO PCT/EP2019/067894 patent/WO2020011626A1/en not_active Ceased
- 2019-07-03 US US17/258,385 patent/US12162815B2/en active Active
-
2020
- 2020-07-30 HR HRP20201198TT patent/HRP20201198T1/hr unknown
- 2020-09-15 CY CY20201100873T patent/CY1123514T1/el unknown
-
2024
- 2024-11-06 US US18/939,410 patent/US20250179005A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021532076A (ja) | 2021-11-25 |
| US12162815B2 (en) | 2024-12-10 |
| EP3594199B1 (en) | 2020-07-01 |
| MX2021000348A (es) | 2021-06-08 |
| EP3594199A1 (en) | 2020-01-15 |
| LT3594199T (lt) | 2020-11-10 |
| SI3594199T1 (sl) | 2020-10-30 |
| CA3105559A1 (en) | 2020-01-16 |
| WO2020011626A1 (en) | 2020-01-16 |
| US20250179005A1 (en) | 2025-06-05 |
| US20210292271A1 (en) | 2021-09-23 |
| CN112654602A (zh) | 2021-04-13 |
| JP7407166B2 (ja) | 2023-12-28 |
| PL3594199T3 (pl) | 2020-11-16 |
| HUE052049T2 (hu) | 2021-04-28 |
| CY1123514T1 (el) | 2022-03-24 |
| PT3594199T (pt) | 2020-09-04 |
| CN112654602B (zh) | 2025-05-16 |
| AU2019303323B2 (en) | 2024-08-22 |
| HRP20201198T1 (hr) | 2020-11-13 |
| AU2019303323A1 (en) | 2021-01-28 |
| ES2815899T3 (es) | 2021-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3594199T3 (da) | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf | |
| DK3784283T3 (da) | Cannabidiopræparater og anvendelser deraf | |
| DK3774789T3 (da) | BRM-målrettede forbindelser og tilhørende fremgangsmåder til anvendelse | |
| DK3796711T3 (da) | Fremgangsmåde og indretning til overdragelse | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3788044T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3625263T3 (da) | Anti-galectin- 9-antistoffer og anvendelser deraf | |
| DK3601358T5 (da) | Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3618863T3 (da) | Anti-tigit-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3383916T3 (da) | Anti-CD73-antistoffer og anvendelser deraf | |
| DK3788045T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3689076T3 (da) | PDCP-UL-opdeling og forbehandling | |
| DK3668512T3 (da) | Pyruvatkinasemodulatorer og anvendelse deraf | |
| DK3265947T3 (da) | Fremgangsmåde og system til kryptering | |
| DK3529257T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK4105223T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3828194T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| IL268815A (en) | Compositions and methods for tumor transduction | |
| DK3596125T3 (da) | Anti-PAR2-antistoffer og anvendelser deraf | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3240895T3 (da) | Sammensætninger og fremgangsmåder til proteinglykosylering | |
| DK3704227T3 (da) | Sammensætning og fremgangsmåde | |
| DK3812392T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3692009T3 (da) | Biocementationsfremgangsmåde og system |